Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Ultrasound Enhanced Delivery of Therapeutics

NCT04821284 is registered in ClinicalTrials.gov with Flemming Forsberg as lead sponsor.

NCT NCT04821284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04821284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Ultrasound Enhanced Delivery of Therapeutics
Lead sponsor
Flemming Forsberg
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
December 6, 2021
Completion date
February 28, 2026
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced pancreatic ductal adenocarcinoma, metastatic pancreatic ductal adenocarcinoma, stage ii pancreatic cancer ajcc v8, stage iia pancreatic cancer ajcc v8, stage iib pancreatic cancer ajcc v8, stage iii pancreatic cancer ajcc v8, stage iv pancreatic cancer ajcc v8, unresectable pancreatic ductal adenocarcinoma